Category Press Releases

Gameto

Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study

Gameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study Gameto, a clinical-stage biotechnology company at the forefront of developing cutting-edge iPSC (induced pluripotent stem cell)-based therapies to revolutionize fertility care, today announced an exciting milestone in its…

Read MoreGameto Launches First U.S. Clinical Site for Patient Enrollment in Fertilo Study
Creyon Bio

Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships

Creyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships Creyon Bio, a biotechnology company pioneering the use of artificial intelligence in oligonucleotide therapy development, has announced a major leadership transition with the appointment of Serge…

Read MoreCreyon Bio Names Industry Veteran Serge Messerlian as CEO to Drive Growth and Partnerships
TNF

TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery

TNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery In a significant advancement for data-driven drug development, TNF Pharmaceuticals has announced a strategic collaboration with Renova Health to harness artificial intelligence (AI) and machine learning (ML) technologies in…

Read MoreTNF Pharmaceuticals and Renova Health Harness AI to Fast-Track Drug Discovery
Uniphar

Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone

Uniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone In a significant advancement that underscores its continued investment in next-generation healthcare solutions, Uniphar, a global leader in pharmaceutical and medtech services, has officially launched its 10th cell and…

Read MoreUniphar Expands Cell and Gene Therapy Portfolio with Tenth Project Milestone
QIAGEN

QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025

QIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025 QIAGEN N.V. Frankfurt Prime Standard: QIA), a global leader in molecular diagnostics and sample-to-insight technologies, today announced a comprehensive lineup of product innovations and…

Read MoreQIAGEN Highlights Breakthroughs in Cancer Genomics and Announces Key Partnership Updates at AACR Annual Meeting 2025
Cytokinetics

Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes meaningful equity incentives. On April 15, 2025, the company announced…

Read MoreCytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4)